In the Article “High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies” by C.A. Mecoli et al.,1 the Acknowledgments section should include the following: “CAM was supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant T32AR048522.” The authors regret the omission.
- © 2018 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
What's happening in Neurology® Neuroimmunology & Neuroinflammation
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor
High-dose cyclophosphamide without stem-cell rescue for refractory CIDP